Fungal super infection in COVID 19 patients and role of antifungal stewardship |
Journal Updates
eMediNexus Coverage from: 
Fungal super infection in COVID 19 patients and role of antifungal stewardship

0 Read Comments                

The presence of fungal super infection, specifically invasive pulmonary aspergillosis (IPA), in patients with COVID-19, has become a cause of great concern. Although this disease occurs in immune-compromised, the isolated reports indicate its increased risk in patients with COVID-19 who are non-immuno-compromised at baseline.Voriconazole remains the first-line treatment for IPA and must be monitored for neurotoxicity and hepatoxicity and drug-drug interactions.A study reports no increase in Anti...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now